Adam Clammer, chair of the board and a director of Cellebrite, filed an initial statement of beneficial ownership. The filing reported 71,396 ordinary shares held directly. It also reported 13.86 million ordinary shares held indirectly through TWC Tech Holdings II. In addition, the filing reported 375,000 ordinary shares held indirectly through a long term trust. It also reported 375,000 ordinary shares held indirectly through a joint revocable trust.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellebrite DI Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-029607), on March 18, 2026, and is solely responsible for the information contained therein.
Comments